MEDIGROUP: what changed
What changed
MEDIGROUP
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Net result for the year
-€201,774
2024 · €3.9m-€4.1m
Equity
€23.7m
2024 · €23.9m-€201,774
Cash
€502,317
2024 · €71,199+€431,118
Balance sheet total
€30.2m
2024 · €29.6m+€622,870
Largest movements
Assets
- Cash +€431,118
up €431,118 (+606%), from €71,199 to €502,317
mainly Other debts (+€893,487) and Trade debts (+€55,750)
Equity and liabilities
- Other debts +€893,487
up €893,487 (+19.0%), from €4.7m to €5.6m
Income statement
- Financial income -€2.7m
down €2.7m (-70.9%), from €3.8m to €1.1m
- Gross operating margin -€1.3m
down €1.3m (-63.8%), from €2.0m to €720,134
- Taxes -€348,885
down €348,885 (-96.4%), from €361,885 to €13,000
- Staff costs +€324,876
up €324,876 (+24.6%), from €1.3m to €1.6m
- Financial charges +€95,539
up €95,539 (+38.6%), from €247,768 to €343,307
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€3.9m
Gross operating margin
-€1.3m
Staff costs
-€324,876
Depreciation
+€28,499
Other operating charges
-€11,419
Other operating items
-€9,243
Financial income
-€2.7m
Financial charges
-€95,539
Taxes
+€348,885
Result 2025
-€201,774
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€436,025
Investment
-€4,907
Financing
€0
Cash 2024
€71,199
From operations (derived)
+€436,025
Net result for the year
-€201,774
Depreciation
+€15,744
Receivables within one year
-€146,349
Deferred charges and accrued income
-€56,240
Trade debts
+€55,750
Tax, wage and social debts
-€124,594
Other debts
+€893,487
Investment (derived)
-€4,907
Investment in fixed assets (net)
-€4,907
Cash 2025
€502,317
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €29,555,043 | €30,177,913 | +€622,870 | +2.1% |
| Fixed assets | 21/28 | €13,883,233 | €13,872,396 | -€10,837 | -0.1% |
| Intangible fixed assets | 21 | €20,121 | €13,876 | -€6,245 | -31.0% |
| Tangible fixed assets | 22/27 | €20,054 | €15,462 | -€4,592 | -22.9% |
| Plant, machinery and equipment | 23 | €887 | €124 | -€763 | -86.0% |
| Furniture and vehicles | 24 | €1,363 | - | -€1,363 | |
| Other tangible fixed assets | 26 | €17,804 | €15,338 | -€2,466 | -13.9% |
| Financial fixed assets | 28 | €13,843,058 | €13,843,058 | = | 0.0% |
| Current assets | 29/58 | €15,671,810 | €16,305,517 | +€633,707 | +4.0% |
| Amounts receivable within one year | 40/41 | €15,550,332 | €15,696,681 | +€146,349 | +0.9% |
| Trade receivables | 40 | €1,280,496 | €1,737,923 | +€457,427 | +35.7% |
| Other amounts receivable | 41 | €14,269,836 | €13,958,758 | -€311,078 | -2.2% |
| Cash at bank and in hand | 54/58 | €71,199 | €502,317 | +€431,118 | +606% |
| Deferred charges and accrued income | 490/1 | €50,279 | €106,518 | +€56,240 | +112% |
| Total equity and liabilities | 10/49 | €29,555,043 | €30,177,913 | +€622,870 | +2.1% |
| Equity | 10/15 | €23,891,912 | €23,690,139 | -€201,774 | -0.8% |
| Contributions | 10/11 | €9,068,510 | €9,068,510 | = | 0.0% |
| Capital | 10 | €9,068,159 | €9,068,159 | = | 0.0% |
| Issued capital | 100 | €9,068,159 | €9,068,159 | = | 0.0% |
| Contributions outside capital | 11 | €351 | €351 | = | 0.0% |
| Share premium | 1100/10 | €351 | €351 | = | 0.0% |
| Reserves | 13 | €906,816 | €906,816 | = | 0.0% |
| Non-distributable reserves | 130/1 | €906,816 | €906,816 | = | 0.0% |
| Legal reserve | 130 | €906,816 | €906,816 | = | 0.0% |
| Profit (loss) carried forward | 14 | €13,916,586 | €13,714,813 | -€201,774 | -1.4% |
| Amounts payable | 17/49 | €5,663,130 | €6,487,774 | +€824,644 | +14.6% |
| Amounts payable within one year | 42/48 | €5,663,130 | €6,487,774 | +€824,644 | +14.6% |
| Trade debts | 44 | €336,729 | €392,479 | +€55,750 | +16.6% |
| Suppliers | 440/4 | €336,729 | €392,479 | +€55,750 | +16.6% |
| Taxes, remuneration and social security | 45 | €620,340 | €495,746 | -€124,594 | -20.1% |
| Taxes | 450/3 | €402,533 | €245,250 | -€157,282 | -39.1% |
| Remuneration and social security | 454/9 | €217,808 | €250,496 | +€32,688 | +15.0% |
| Other amounts payable | 47/48 | €4,706,061 | €5,599,548 | +€893,487 | +19.0% |
| Remuneration, social security and pensions | 62 | €1,318,044 | €1,642,920 | +€324,876 | +24.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €44,243 | €15,744 | -€28,499 | -64.4% |
| Other operating charges | 640/8 | €965 | €12,384 | +€11,419 | +1,183% |
| Non-recurring operating charges | 66A | - | €9,243 | +€9,243 | |
| Gross operating margin | 9900 | €1,989,825 | €720,134 | -€1.3m | -63.8% |
| Operating profit (loss) | 9901 | €626,572 | -€960,157 | -€1.6m | |
| Financial income | 75/76B | €3,835,192 | €1,114,690 | -€2.7m | -70.9% |
| Recurring financial income | 75 | €3,835,192 | €1,114,690 | -€2.7m | -70.9% |
| Financial charges | 65/66B | €247,768 | €343,307 | +€95,539 | +38.6% |
| Recurring financial charges | 65 | €247,768 | €343,307 | +€95,539 | +38.6% |
| Profit (loss) for the period before taxes | 9903 | €4,213,997 | -€188,774 | -€4.4m | |
| Income taxes | 67/77 | €361,885 | €13,000 | -€348,885 | -96.4% |
| Profit (loss) for the period | 9904 | €3,852,111 | -€201,774 | -€4.1m | |
| Profit (loss) for the period to be appropriated | 9905 | €3,852,111 | -€201,774 | -€4.1m |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.